×
About 218 results

ALLMedicine™ Anaplastic Ependymoma Center

Research & Reviews  78 results

Unusual Case of Multilevel Spinal Anaplastic Ependymoma: Case Report.
https://doi.org/10.1017/cjn.2022.310
The Canadian Journal of Neurological Sciences. Le Journal... Tarzi C, Alnemari AM et. al.

Oct 28th, 2022 - Unusual Case of Multilevel Spinal Anaplastic Ependymoma: Case Report.|2022|Tarzi C,Alnemari AM,Woulfe J,Drake B,|

Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ep...
https://doi.org/10.21873/anticanres.15878
Anticancer Research; DE Laclos XC, Frappaz D et. al.

Jul 28th, 2022 - Anaplastic ependymoma is a rare cancer of the central nervous system. The treatment includes optimal resection with focal radiotherapy. Some case reports or retrospective studies have suggested efficacy of regimens containing platinum or bevacizum...

Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
https://clinicaltrials.gov/ct2/show/NCT03727841

Jul 27th, 2022 - Background: Ependymomas are rare primary brain tumors arising from radial glial stem cells. They comprise 5.2% of all pediatric primary brain tumors and 1.9% of all adult primary brain tumors. The standard therapy for newly diagnosed ependymoma is...

Carboplatin and Bevacizumab for Recurrent Ependymoma
https://clinicaltrials.gov/ct2/show/NCT01295944

May 17th, 2022 - Background: Ependymomas are glial based tumors arising from the ependymal lining of the ventricular system and central canal of the spinal cord These tumors affect both adults and children and represent approximately 1.2%-7.8% of all intracranial ...

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
https://clinicaltrials.gov/ct2/show/NCT03434262

Apr 4th, 2022 - Patients will be stratified by the molecular and histologic characteristics of their tumor to one of three treatment strata. STRATUM A: Combination Treatment: ribociclib and gemcitabine. Patient Population: Participants with a diagnosis of refract...

see more →

Clinicaltrials.gov  5 results

Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
https://clinicaltrials.gov/ct2/show/NCT03727841

Jul 27th, 2022 - Background: Ependymomas are rare primary brain tumors arising from radial glial stem cells. They comprise 5.2% of all pediatric primary brain tumors and 1.9% of all adult primary brain tumors. The standard therapy for newly diagnosed ependymoma is...

Carboplatin and Bevacizumab for Recurrent Ependymoma
https://clinicaltrials.gov/ct2/show/NCT01295944

May 17th, 2022 - Background: Ependymomas are glial based tumors arising from the ependymal lining of the ventricular system and central canal of the spinal cord These tumors affect both adults and children and represent approximately 1.2%-7.8% of all intracranial ...

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
https://clinicaltrials.gov/ct2/show/NCT03434262

Apr 4th, 2022 - Patients will be stratified by the molecular and histologic characteristics of their tumor to one of three treatment strata. STRATUM A: Combination Treatment: ribociclib and gemcitabine. Patient Population: Participants with a diagnosis of refract...

Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
https://clinicaltrials.gov/ct2/show/NCT00027846

Aug 7th, 2019 - OBJECTIVES: Determine the local control and pattern of failure in children with completely resected, differentiated, supratentorial localized ependymoma after initial surgical resection alone. Determine the rate of complete resection with second s...

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
https://clinicaltrials.gov/ct2/show/NCT00002463

Feb 18th, 2013 - OBJECTIVES: I. Determine the efficacy of high-dose methotrexate (HMTX) in combination with mechlorethamine, vincristine, prednisone, and procarbazine (MOPP) in infants or young children with primitive neuroectodermal tumors (PNET) (including medul...

see more →

News  2 results

Oncolytic Virus Shows Early Promise in Glioma
https://www.onclive.com/view/oncolytic-virus-shows-early-promise-in-glioma

Dec 20th, 2020 - Frederick F. Lang, MD The oncolytic virus Delta-24-RGD can infect, replicate, and kill glioma cells in patients, according to phase I research presented at the 2014 Society for Neuro-Oncology (SNO) Annual Meeting in Miami. Delta-24-RGD is a nove...

Expert Discusses Molecular Analysis and Treatment Options in Pediatric Ependymoma
https://www.onclive.com/view/expert-discusses-molecular-analysis-and-treatment-options-in-pediatric-ependymoma

Dec 4th, 2020 - Santhosh A. Upadhyaya, MD Among pediatric patients with ependymoma, investigators found no difference in 4-year survival by molecular subgroups, according to results from the SJYC07 trial presented at the 2018 ASCO Annual Meeting. Among patients...

see more →

Patient Education  2 results see all →